Šalis: Malaizija
kalba: anglų
Šaltinis: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
LEVETIRACETAM
HEALOL PHARMACEUTICALS SDN. BHD.
LEVETIRACETAM
3 blisters x 10 Tablets; 10 blisters x 10 Tablets
Pharmathen S.A.
LEVEVITAE ® 500MG Levetiracetam (500mg) film-coated tablets 1 _CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP)_ WHAT IS IN THIS LEAFLET 1. What Levevitae is used for 2. How Levevitae works 3. Before you use Levevitae 4. How to use Levevitae 5. While you are using it 6. Side effects 7. Storage and Disposal of Levevitae 8. Product Description 9. Manufacturer and Product Registration Holder 10. Date of revision WHAT LEVEVITAE IS USED FOR Levevitae is used: • on its own in adults and adolescents from 16 years of age with a certain type of newly diagnosed epilepsy. Epilepsy is a condition where the patients have repeated fits (seizures). Levetiracetam is used for the epilepsy form in which the fits initially affect only one side of the brain, but could thereafter extend to larger areas on both sides of the brain (partial onset seizures with or without secondary generalization). Levevitae has been given to you by your doctor to reduce the number of fits. • as an add-on to other antiepileptic medicines to treat: - partial onset seizures with or without secondary generalization in adults and children from 4 years of age with epilepsy. - myoclonic seizures (short, shock-like jerks of a muscle or group of muscles) in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy - primary generalized tonic-clonic seizures (major fits, including loss of consciousness) in adults and children from 12 years of age with Idiopathic Generalized Epilepsy. HOW LEVEVITAE WORKS • Alone (without another anti-epileptic drug) in patients from 16 years of age with newly diagnosed epilepsy, to treat partial onset seizures with or without secondary generalization. • Together with other anti-epileptic medicines to treat: – The partial onset seizures with or without generalization in patients from 4 years of age. – Myoclonic seizures in patients 12 years and older with juvenile myoclonic epilepsy. – Primary generalised tonic-clonic seizures in patients from 12 years of age with generalized idiopathic epilepsy. BE Perskaitykite visą dokumentą